Gibson Oncology Expands Its Board of Directors With Accomplished Leadership in Oncology Clinical Development and Corporate Strategy
MIAMI, FL / ACCESSWIRE / March 14, 2023 / Gibson Oncology, a privately held Oncology preclinical and clinical development company advancing novel, targeted small molecule